NEW YORK (GenomeWeb News) – Specialty laboratory Physician's Choice Laboratory Services today announced it has acquired the assets of MultiGen Diagnostics for an undisclosed amount.

The deal includes full access to and control of the commercialization of MultiGen's platform technology, which PCLS said "greatly reduces the cost of delivering targeted molecular diagnostics and genetic mutation analysis."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.

A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.

Researchers report that paternally inherited genes are more likely to be expressed in mice.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.